Clinical Trial Update: Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rifaximin versus placebo for prevention of encephalopathy in patients treated with TIPS in cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Cirrhosis | Phase 3 | Status: COMPLETED